Updates in Splenic and Nodal Marginal Zone Lymphoma
December 19, 2017
This video reviews updates on the treatment and biology of splenic and nodal marginal zone lymphoma.
Catherine Thieblemont, MD, PhD
Splenic Marginal Zone Lymphoma: Current Knowledge and Future Directions
February 15, 2012
In this article, we review the current knowledge on the biological findings, clinical features, and therapeutic approaches for splenic marginal zone lymphoma.
Nodal Marginal Zone B-Cell Lymphoma: A Diagnostic and Therapeutic Dilemma
January 17, 2012
The aim of this review is twofold: to summarize descriptions of the clinical presentation provided in published series in order to help clinicians recognize and treat patients, and to discuss diagnostic difficulties faced by hematopathologists when dealing with these lesions and others in the differential diagnosis that must be distinguished from one another.
MALT Lymphomas: Pathogenesis Can Drive Treatment
November 16, 2011
Marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma is an indolent B-cell non-Hodgkin lymphoma arising from the lymphoid tissue at extranodal sites.
Activity of Rituximab in Extranodal Marginal Zone Lymphomas (MALT Type)
March 1, 2002
This phase II study aimed to evaluate the tolerability and activity of the monoclonal anti-CD20 antibody rituximab (Rituxan) in patients with either untreated or relapsed biopsy-proven extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) type, with measurable or evaluable disease.
